Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Array Technologies
Boulder, Colorado, United Stateslinkedin.com ↗
- Ownership
- Private
- Employees
- ~350
- Development stage
- Commercial
01
Overview
Array BioPharma developed multiple FDA-approved small molecule oncology drugs including encorafenib ("BRAFTOVI") and binimetinib ("MEKTOVI"), both now commercialized by Pfizer. Other discoveries include selumetinib ("KOSELUGO", licensed to AstraZeneca), tucatinib ("TUKYSA", owned by Seagen), adagrasib ("KRAZATI", with Mirati Therapeutics), and larotrectinib ("VITRAKVI", licensed to Loxo Oncology/Eli Lilly). The company was recognized for its robust drug discovery engine focused on targeted therapies in oncology[8][9].
- Therapeutic areas
- OncologyRare DiseasesOther
- Modalities
- Small moleculeMonoclonal antibody (limited programs)Biosimilar (limited programs)
- Industry
- Biotech
02
Partnerships
AstraZeneca (selumetinib)Eli Lilly/Loxo Oncology (larotrectinib)Mirati Therapeutics (adagrasib)Seagen/Biogen Idec/Others historically
Beyond the preview
Go deeper on Array Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Array Technologies.